CanSino Biologics Inc. (SHA:688185)

CanSino Biologics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12,323	10,910	11,338	24,494	53,859	62,658
Market Cap Growth	41.87%	-3.78%	-53.71%	-54.52%	-14.04%	434.03%
Enterprise Value	11,239	9,681	9,611	21,112	48,000	57,599
Last Close Price	66.20	61.05	74.52	146.02	298.00	372.18
PE Ratio	-	-	-	-	28.13	-
PS Ratio	14.18	12.89	31.75	23.68	12.53	2517.38
PB Ratio	2.52	2.22	2.14	3.38	6.30	10.32
P/TBV Ratio	2.57	2.28	2.21	3.75	6.89	10.38
P/FCF Ratio	-	-	-	-	63.60	-
P/OCF Ratio	-	-	-	-	26.27	-
EV/Sales Ratio	13.18	11.44	26.92	20.41	11.16	2314.14
EV/EBITDA Ratio	-	-	-	-	25.96	-
EV/EBIT Ratio	-	-	-	-	26.91	-
EV/FCF Ratio	-24.25	-	-	-	56.68	-
Debt / Equity Ratio	0.41	0.41	0.51	0.37	0.16	0.02
Debt / EBITDA Ratio	-	-	-	-	0.74	-
Debt / FCF Ratio	-	-	-	-	1.62	-
Asset Turnover	0.11	0.10	0.03	0.09	0.46	0.01
Inventory Turnover	0.71	0.83	1.55	1.57	2.48	0.16
Quick Ratio	2.42	2.38	1.86	2.33	2.78	12.54
Current Ratio	2.65	2.54	2.02	2.64	3.25	13.24
Return on Equity (ROE)	-4.40%	-7.52%	-31.40%	-12.22%	26.09%	-10.52%
Return on Assets (ROA)	-2.17%	-2.74%	-10.36%	-8.03%	11.97%	-7.58%
Return on Capital (ROIC)	-2.47%	-3.18%	-12.01%	-9.43%	13.82%	-8.24%
Return on Capital Employed (ROCE)	-	-	-	-	19.80%	-
Earnings Yield	-1.79%	-3.47%	-13.08%	-3.71%	3.55%	-0.63%
FCF Yield	-3.76%	-5.73%	-13.39%	-11.95%	1.57%	-1.02%
Dividend Yield	-	-	-	-	0.27%	-
Payout Ratio	-	-	-	-	0.74%	-
Buyback Yield / Dilution	1.38%	-0.38%	0.17%	0.08%	-7.26%	-
Total Shareholder Return	-	-0.38%	0.17%	0.08%	-6.99%	-

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.